A team of scientists led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have released one of the world's largest ...

SK bioscience won a patent case against Moderna in Korea, impacting mRNA technology development and potential vaccine exports ...

Bin Wu, associate professor in the department of Biophysics and Biophysical Chemistry at the School of Medicine, visited ...

SK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has achieved a "final victory" in a ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The YieldMax Magnificient 7 Fund of Option Income ETFs has outperformed the market since launch but I do not expect that to ...

Learn more about whether Moderna, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which ...

US stocks skyrocketed higher after President Donald Trump announced that he authorized a 90-day pause on the “reciprocal” tariffs that had gone into effect Wednesday, with the exception of ...

Looking at options history for Moderna MRNA we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...